Nancy E. Davidson

发表

Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells

Michele D. Sobolewski, N. Davidson, Madhavi Billam, 2010, Breast Cancer Research and Treatment.

Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer.

Nita Ahuja, Adam Brufsky, Stephen B. Baylin, 2014 .

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine

Dipali Sharma, N. Davidson, J. Keen, 2003, Breast Cancer Research and Treatment.

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

George W. Sledge, David L. Page, Robert Gray, 2013, Journal of the National Cancer Institute.

The molecular landscape of premenopausal breast cancer

Rohit Bhargava, George C. Tseng, Tianzhou Ma, 2015, Breast Cancer Research.

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

Zhe Zhang, David A. Flockhart, Daniel F. Hayes, 2012, Breast Cancer Research and Treatment.

Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer

Jian Chen, Steffi Oesterreich, Adrian V. Lee, 2014, Science Translational Medicine.

Estrogen Receptor α Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death

Yi Huang, Weimin Fan, B. Park, 2007 .

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines

Zhe Zhang, Michele D. Sobolewski, Zhe Zhang, 2010, Cancer Chemotherapy and Pharmacology.

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Molin Wang, George W. Sledge, Antonio C. Wolff, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.